Related by context. All words. (Click for frequent words.) 64 segmental 64 MANAGEMENT DISCUSSION AND ANALYSIS 62 Segmental analysis 61 Segment EBIT 61 -Lighting Designers 60 Cash Flow Statement 60 IFRS IFRS 60 MSEK -# [001] 60 Pro Forma EBITDA 60 Peripheral vascular 60 GROUP RESULTS 60 Adjusted OIBDA Margin 60 SIGNIFICANT ACCOUNTING POLICIES 60 Supplementary Data 60 GBPm GBPm GBPm 60 GBPm GBPm 59 Exceptional Items 59 Orthopedic Implants 59 -Subscribes 59 REAL ESTATE BUSINESS 59 Normalized EBIT 59 Q2 FY# [001] 59 unaudited Consolidated Statements 59 Before Unusual Items 58 Segment Highlights 58 ended September# 58 Maintenance Capital Expenditures 58 Unallocated Corporate 58 GBPm 58 Segmented 58 Comparative Figures 58 FY# FY# FY# 58 Balance Sheet Cash Flow 58 Gross Premiums Written 58 SEGMENT INFORMATION 58 FINANCIAL STATEMENTS FOR 58 Equity Investees 58 Consolidated EBITDAR 57 -DL Albert Haynesworth 57 Reviewed Reviewed 57 -Kahaani Ghar Ghar Ki 57 Pro Forma Results 57 GAAP Adj 57 Sensitivity Analysis 57 #-#/# #-#/# [006] 57 continuingoperations 57 Rm Rm 57 Inorganic Chemicals 57 prioryear 57 Variance Analysis 57 Non GAAP Operating Margin 57 operatingincome 57 nine monthsended 56 FY# FY# [002] 56 Appendix 4D 56 Guides FY# 56 [004] 56 Contribution Margin 56 -Genereaux 56 excluding BIBP 56 Specified Items 56 -Edgewater Networks 56 Constant Currency 56 Adtegrity.com Reports 56 EBITDAA 56 non GAAP Measures 56 Pro forma Adjusted EBITDA 56 Comparable EBITDA 56 Predecessor Predecessor 56 Non IFRS 56 excluding reimbursables 56 Vinyls segment 56 SEGMENTED INFORMATION 56 Underwriting Income Loss 56 - Adjusted [030] 56 PremierWest Bancorp Announces 56 H1 FY# [001] 56 Non Recurring 56 Consolidated Condensed Statement 56 Segmented Results 56 DKKm 56 BUSINESS SEGMENTS 56 Appendix 4E 56 -Keops 56 AUDIOCODES LTD 56 = Operating [002] 56 Supplemental Figure 56 HY1 56 Stent Placement 56 adjusted1 56 GAAP EARNINGS 56 Tikcro Technologies Reports 56 Gypsum Wallboard 56 ATOI 56 Elimin 56 Normalized EBITDA 56 -Paroa 55 - Three MZigWheels 55 Cash Flow Statements 55 Cholinesterase Inhibitors 55 Third Consecutive Quarter 55 Adjusted EBIT 55 Enventis Sector 55 Condensed Cash Flow 55 - - [006] 55 Adjusted Cash Flow 55 9M FY# [001] 55 Factors Impacting 55 Olefins Polyolefins 55 H1 FY 55 -AL Gustin 55 intersegment eliminations 55 Reported ments 55 Pro forma EBITDA 55 normalized EBIT 55 Q3 FY'# 55 NOK#.#m 55 MNOK #,# 55 Content Outline 55 months endedSeptember 55 Adjusted EBITDA1 55 Incr 55 Residential Furnishings 55 Segmental Analysis 55 Q#/# Q#/# [001] 55 Appendix 4C 55 -Amneal Pharmaceuticals LLC 55 Refractories segment 55 Pro forma adjusted EBITDA 55 Main Outcome Measures 55 EBITDA1 55 Competitive Wireline 55 WESTWOOD ONE INC. SUPPLEMENTAL 55 - -Hector Allende 55 #.#. #.#.# [002] 55 Sequential Quarterly 55 PTOI 55 Cost Structure 55 DAC offsets 55 CRITICAL ACCOUNTING ESTIMATES 55 Clinical Outcome 55 Non Gaap 55 2Q FY# [001] 55 #H# #H# 55 UNITS SOLD 55 ROCA Reports 55 Qtr Qtr 55 Normalised 55 CONSOLIDATED RESULTS 55 SMURFIT STONE CONTAINER CORPORATION 55 * Reclassified 55 Vertebral Fractures 55 Pro Forma EPS 55 Results Exceed Expectations 55 #compared 55 Magnesia Specialties 54 Achieves Positive 54 Releases Audited 54 LOSS ACCOUNT 54 ascompared 54 Bone Graft Substitutes 54 EBITDAF 54 See Attachment 54 Regulated Businesses 54 operating income1 54 Saehan Bancorp Reports 54 Q#/FY# 54 Individual Annuities segment 54 Beverage Concentrates 54 XPEL Announces 54 Computations 54 -Hua Tian 54 Backs FY# 54 - Babelgum Online 54 -Tyrell Fenroy 54 3q 54 Qtr Qtr Qtr Qtr 54 Modifiable 54 Segmented Information 54 SEK -#.# -#.# [002] 54 Premiums Written 54 Reconciling Items 54 SEK -#.# -#.# [003] 54 Near Infrared Optics 54 OPERATING SEGMENTS 54 Previous Corresponding Period 54 SEGMENT DATA 54 Custom Sheet 54 Supermetals Business 54 COMPANY CONSOLIDATED INCOME STATEMENTS 54 Histopathologic 54 Affirms FY# 54 SECOND QUARTER HIGHLIGHTS 54 Condensed consolidated 54 Randomized Clinical Trials 54 Operating Expense Ratio 54 non gaap 54 Q2 F# 54 AND PRO FORMA 54 - Adjusted [013] 54 - Adjusted [026] 54 Condensed Consolidated Interim 54 HealthStream Learning 54 intersegment revenues 54 Revises FY# 54 Synthetic Fuel 54 Tumor Response 54 totaled EUR#.#m 54 Inflammatory Pain 54 Computed 54 FINANCIAL DETAILS 54 Predecessor Period 54 Distribution Coverage Ratio 54 -megabases 54 Recurring Adj 54 Oxy ER 54 Comparability 54 Mexico Pressure Pumping 54 THE YEAR ENDED 54 -Ganga aarti 54 Adjusted EBITDAX 54 Gross Margin Gross 54 pro forma adjusted EBITDA 54 -Tomine 54 Commercial Fixturing & 54 FINANCIAL OVERVIEW 54 Headline PBIT 54 Q#'# Q#'# 54 Match Fixtures 54 = Non GAAP [005] 54 FINANCIAL REVIEW 54 Reviewed Audited 54 Six Months Months 54 interim condensed consolidated 54 Nine Months Months 54 SIX MONTHS ENDED 54 Currency Translation 54 Tax Expense 54 nonGAAP 54 Vertebral Fracture 54 Consolidated Cash Flow 54 Reportable segment 54 EDITDA 54 EUR -#.# [001] 54 Adjusted Operating Expenses 54 SUMMARY INCOME STATEMENTS 54 Product Types 54 OPERATING HIGHLIGHTS 54 Engineered Products segment 54 millioncompared 54 Profitability Ratios 54 Bingo.com Announces 54 Unaudited Interim 54 HALF YEAR ENDED 53 Underlying EBIT 53 CONSOLIDATED FINANCIAL STATEMENTS 53 -#,# -# 53 Sleep Apnea Diagnostic 53 - Operating [014] 53 IDEXX Laboratories Announces 53 Inventory Valuation 53 1Q FY# 53 Condensed Consolidated Income 53 Second Quarter Highlights 53 Industrial CFOA 53 Pro forma EPS 53 -Josephine Marcotty 53 Managements Discussion 53 Estimated Estimated 53 GYN Surgical 53 SEK -#.# [003] 53 - - [041] 53 Nucleic Acids 53 #-#/# [004] 53 Revises Third Quarter 53 Preliminary Third Quarter 53 Disposable Protective Apparel 53 Variance Variance 53 AGY Asia 53 Segment 53 Synalloy Corporation Announces 53 Rs.#.# Crores [001] 53 CNY#.# Billion 53 Non GAAP adjustments 53 -#,# -#,# -#,# -#,# [003] 53 Unaudited Condensed Consolidated 53 - Adjusted [018] 53 Profit Margin 53 -Lake Andrusia 53 ORIENT EXPRESS HOTELS LTD 53 AND FINANCIAL POSITION 53 Dry Powder Inhalers 53 Unaudited Pro Forma 53 - Non GAAP [031] 53 Annualized Adjusted EBITDA 53 AND SUBSIDIARIES SEGMENT REPORTING 53 Semiannual Financial 53 CICA Accounting Guideline 53 Discontinued Businesses 53 Accounting Policies 53 - Adjusted [007] 53 Consolidated Condensed Financial 53 FINANCIAL CONDITION AND 53 Record Second Quarter 53 Wtd 53 Half Yearly Report 53 Pretax Income 53 Items Affecting Comparability 53 Carotid Stenting 53 Surgical Procedures 53 Reduces Quick Facts 53 Univariate 53 [014] 53 ACCOUNTING POLICIES 53 Mitotic 53 Unlevered Free Cash Flow 53 CorVel Announces 53 Month Period 53 Competitive Scenario 53 Statutory Accounts 53 #.#mln [007] 53 Capital Employed 53 International Liftboats 53 Qtr Ended 53 Comorbidities 53 Supplemental Table 53 unaudited consolidated balance sheets 53 SEACOR Holdings Announces 53 Womacks Adjusted EBITDA 53 Audited Financials 53 Double Blind Randomized 53 -Ignacio Galan 53 Cautionary Information 53 AMEX aac 53 FINANCIAL STATEMENTS 53 Sequential Growth 53 Prolongs Survival 53 -ABGL 53 EBITDAC 53 OSIs 53 Pro Rata 53 Histologic 53 -Inc. Amex IAO 53 -DEAD BODY 53 -Soft soled shoes 53 Operational EBITDA 53 MSEK -# [002] 53 -John F. Biemeck 53 Exceed Forecast 53 #,#.# #,#.# [008] 53 Appendix 5B 53 Wajax Income Fund 53 Q2 Q2 Ytd 53 TOFUTTI Announces 53 ATCF 53 Expects FY# 53 netincome 53 FINANCIAL RESULTS SUPPLEMENTAL 53 accompanying condensed consolidated 53 Third Quarter Nine Months 53 condensed consolidated 53 Adjusted Non GAAP 53 Non GAAP Measure 53 THIRD QUARTER HIGHLIGHTS 53 - Non GAhornbeams lining 53 - - [012] 53 Q2 FY'# 53 -Von Hippel Lindau 53 Upward Revision 53 itures 53 Six Month Periods 53 EBITD 53 Profit Rises Quick Facts 53 BANJO 53 Branded Tape 53 REVPAR Occupancy Rate 53 Randomized Trials 53 Breast Tumors 53 Dispersive 53 - -OfficeMax ImPress R 53 Successor Successor 53 YEAR YEAR 53 GBPm GBPm GBPm GBPm 53 Month Period Ended 53 Use Segments 53 Goodwill Impairment 53 Months Months 53 Dyslipidemia 53 AND CASH FLOW 53 Summarized below 53 Recent Accounting Pronouncements 53 Arch Neurol 53 = Operaanalytic geometry 53 Supplemental Schedule 52 EPS Excl 52 NON GAAP MEASURES 52 SEGMENT REPORTING 52 LIST OF FIGURES 52 Xenonics Announces 52 Modulates 52 Rs#mn [001] 52 Vyvx Advertising Distribution 52 PRO FORMA 52 Rs.#.# Crores [002] 52 SEGMENT RESULTS 52 Supplementary Table 52 B.1 52 - Adjusted [033] 52 Nine Month 52 Comparative Condensed Consolidated Statements 52 Normalized Basis 52 =eReader.com 52 Epitaxial 52 Restructuring Charges 52 -Coco Reef 52 Additive Technologies 52 unannualized 52 -Employment Eligibility Verification 52 intersegment transactions 52 OPERATING RESULTS 52 Foreign Currency Translation 52 Adjusted Ebitda 52 ANNUAL REPORT 52 adjusted ebitda 52 netsales 52 Industrial Enzymes 52 -Unprovoked 52 YTD Q3 52 Thallion Announces 52 Adjusted EBITDA Margin 52 OPERATING INFORMATION 52 Rs.#.# crores [006] 52 -irrelevancies 52 Analyte 52 Third Quarter Dividend 52 EBIT Margin 52 Statistical Tables 52 > > > [001] 52 IAROC 52 Projected Release Date 52 Segment Margin 52 LECTRA 52 Timeshare segment 52 totaled EUR#.# 52 #,# #,# #,# [012] 52 Revenues Decline 52 Programmer Paradise segment 52 WELLS FINANCIAL CORP. 52 Plumas Bancorp Reports 52 Q#'# Q#'# Q#'# Q#'# 52 Adjusted Diluted EPS 52 Distressed Assets Portfolio 52 Lifts FY# 52 Pro Forma Operating 52 USE OF NON GAAP 52 GBP'# GBP'# 52 Regulatory Announcement 52 Noninterest Expense 52 Reported Adjustments 52 ROFE 52 Wholesale Leathercraft 52 OPERATING RESULT 52 Uterine Cancer 52 EOG RESOURCES INC. 52 SIC Code 52 Items impacting comparability 52 Unaudited Unaudited Unaudited Audited 52 -Juan'ya Green 52 - - [046] 52 Specialized Products 52 Sequential Revenue 52 Third Quarter Ended 52 #/#/# #/#/# - [002] 52 - - [086] 52 Maintains FY# 52 Loss Narrows Quick Facts 52 -gangplanks 52 Reaches Profitability 52 Visualization Equipment 52 Comparable RevPAR 52 FY# FY# FY# FY# [002] 52 Placebo Controlled Trial 52 INC. UNAUDITED CONDENSED CONSOLIDATED 52 Wood Preservative Chemicals 52 Och Ziff Operating 52 comparedto 52 baseline FEV 52 SunOpta Foods 52 -#:# GMT/# 52 Reveals Significant 52 Cnc 52 Q1 F# 52 Operating Efficiencies 52 5 Yr Avg 52 Aromatase Inhibitors 52 H1 FY# [002] 52 - - [126] 52 Costs Update3 52 adjusted distributable cash 52 EPS Rises 52 Depreciations 52 increaseof 52 Measurement Uncertainty 52 Audited Results 52 Partially offset 52 Winmark Corporation Announces 52 Onshore Downstream 52 -PPEP 52 SEK -#.# [002] 52 YEAR ENDED 52 Interest Coverage Ratio 52 Net Tangible Assets 52 normalized EBITDA 52 - Operating [025] 52 Adjusted Gross Profit 52 Coatings Segment 52 Fourth Quarter Ended 52 MEASUREMENTS 52 - Revenues [016] 52 Pro Forma Revenues 52 - -Casino Atunyote ah 52 - Non GAAP [017] 52 Truckload segment 52 Cash Flow Margin 52 Expandable Polystyrene 52 INC. Summary 52 Engineered Support Structures 52 CHF#.# billion [002] 52 Substantially Improved 52 Reclassified 52 Guides Q4 52 Impairment Charges 52 AIFRS 52 #:#-# [033] 52 #E #E [003] 52 EUR Mio 52 GOL Announces 52 Adverse Event 52 =America Airline Satisfaction 52 Unaudited Second Quarter 52 - -Greg Geoffroy 52 Unaudited Supplemental 52 Centrifugal Pumps 52 Opns 52 Increases Quarterly 52 -squalid shacks 52 Consolidated Cash Flows 52 Adjusted Distributable Cash 52 Olefins segment 52 Continuous Fiber Reinforced 52 - Revenues [006] 52 Pro Forma Adjusted EBITDA 52 OPERATING AND 52 Unaudited Unaudited Audited 52 Noncritical 52 totaled SEK 52 USOGP 52 Double Digit Earnings 52 ileal 52 NeuCo 52 Additions Accrual Basis 52 Rs1 #mn 52 Quantifiable 52 income1 52 Rs#.#mn [001] 52 #,#,# = [009] 52 nm nm 52 Completes Restatement 52 ALT elevation 52 Goodwill Impairment Charge 52 Reportable Segment 52 Non GAAP Gross Margin 52 Tonnes mined 52 PERCENT CHANGE 52 Second Quarter Six Months 52 - Non GAAP [023] 52 - Adjusted [012] 52 Oil MBbl 52 -Cedomir Jovanovic 52 excluding divestments 52 Bone Metastases 52 AirIQ Announces 52 Non GAAP Disclosures 52 #,# #,# [003] 52 Breast Cancer Stem Cells 52 Income Statement 52 Q#/# Q#/# Change 52 Showed Significant 52 tables summarize 52 Product Lines 52 Volume Consumption 52 Parent Entity 52 BioFuel Reports 52 Nymox Reports 52 JPY8 52 EBIT amounted 52 Genetic Markers 52 Drivetrain segment 52 Resilient Flooring 52 NON GAAP FINANCIAL INFORMATION 52 Endometrial Cancer 52 -ANDREA SACHS 52 unaudited condensed 52 - Non Shane Germann 52 Engineered Materials segment 52 FSP FAS #-# 52 GBP#.# Million [001] 52 Randomized Controlled Trials 52 > > [002] 52 Three Months Ending 52 9M FY# [002] 51 Realized Gains 51 -validated Borel 51 Proved Developed Reserves 51 Topics Covered Executive 51 Aortic Aneurysms 51 #,# -#,# [004] 51 ViRexx Announces 51 ESCO Announces 51 Cervical Spine 51 Quarter Fiscal 51 Microstructure 51 Pt Chg 51 -Skaaland 51 Vertebral 51 Intraocular Lenses 51 Q1 FY'# 51 Q#/# Q#/# Q#/# Q#/# [001] 51 - Revenues [017] 51 Rs#.#b [003] 51 Predecessor Successor 51 PPD Declares 51 TSEK 51 Normalised earnings 51 MSEK -#.# 51 Haplotype 51 #Q'# #Q'# 51 Interest Expenses 51 Miscellaneous Manufacturing 51 Fetal Monitors 51 Adjusted Segment 51 efficiency ratio teb 51 FINANCIAL REPORT 51 - -Virginie Ledoyen 51 SUBSIDIARIES Consolidated Statement 51 - -Sam Cammack 51 Cancer Epidemiol Biomarkers Prev 51 -tiger muskies 51 Pro Forma Net 51 NAICS # [001] 51 Comparable Basis 51 Six Months Six Months 51 Provides FY# EPS 51 #,# #,# #,# #,# [004] 51 Q2 YTD 51 Financing Costs 51 YTD YTD 51 Turbine Components Services 51 -#.# % [001] 51 Lifts FY# Revenue 51 endedDecember 51 EOG RESOURCES INC. SUMMARY 51 Ownership Structure 51 Reiterates FY# 51 Qrtr 51 - - [058] 51 Capsular 51 - - Toandrea@andreakay.com 51 SUPPLEMENTAL INFORMATION TO RECONCILE 51 ANOI 51 -# -# [006] 51 Outcome Measures 51 impacting comparability 51 Non GAAP adjusted EBITDA 51 Sequential Quarter 51 Tumor Cell 51 Localized Prostate Cancer 51 Breast Cancer Incidence 51 Explosive Metalworking segment 51 Invoiced 51 Ischemic 51 Audited Consolidated 51 Logistic Regression 51 STATEMENTS Unaudited 51 Hematological Cancers 51 Reconciliation Tables 51 Pro Forma Adjusted 51 nonreportable segment revenues 51 Adjusted pro forma 51 - -osmium 51 - -Corporatism 51 Randomized Evaluation 51 Tecstar Automotive Group 51 -Luukkonen 51 BY GEOGRAPHICAL AREA 51 Performance Styrenics 51 Normalized Earnings 51 Month Avg 51 Cents Cents 51 Flamel Technologies Announces 51 Specialty Engineered Alloys 51 Unaudited Third Quarter 51 FINANCIAL PERFORMANCE 51 FUTURE INCOME TAXES 51 Financial Instruments Disclosures 51 - -Leni Calas baby 51 Q4 F# 51 Operational Metrics 51 Plasma Proteins 51 Recurring FFO 51 YonY 51 3Q FY# 51 -Vado Diomande 51 - RevenuesChhobi 51 Anionic Surfactants 51 Heska Announces 51 4Q FY# 51 Amount NT 51 Restruc 51 distal femur 51 beia 51 Other Specified Items 51 Aerospace Component 51 Visiting Nurse VN 51 Congenital Heart Surgery 51 MEDTOX Scientific Announces 51 Q1 FY# [002] 51 #:#-# [029] 51 Left Ventricular 51 endedSeptember 51 FINANCIAL RESULTS 51 - Operating [028] 51 Beneficial Ownership 51 OCF margin 51 Installed Base 51 Prepaid Processing 51 -Krefeld Germany 51 -#,# -#,# [004] 51 Above Consensus 51 Record Third Quarter 51 Asset Impairment Charge 51 Funds Declare Dividends 51 Quarters Ended Six Months 51 Contract Drilling 51 Automotive Sensors 51 Q3 F# 51 Restate Prior 51 GBP'# GBP'# GBP'# 51 Sequential Increase 51 Bladex Announces 51 g h 51 Refining Segment 51 -mother Arndrea 51 Rs.#.#cr 51 APPENDIX 4D 51 Overhead Costs 51 -tau gene 51 DXP Enterprises Announces 51 Quarter Ended #/#/# #/#/# [001] 51 Various Types 51 CONSOLIDATED CASH FLOW STATEMENT 51 Forward Looking Guidance 51 renal cortical 51 NexgenRx Announces 51 Prognostic Value 51 CAPITAL STRUCTURE 51 Rm Rm Rm 51 RevPAR ADR 51 Virco Announces 51 Gerdau Ameristeel Announces 51 Pro Forma Earnings Per 51 #.#/diluted share 51 - - [020] 51 Supplemental Non GAAP 51 BY BUSINESS SEGMENT 51 Revenue Grows 51 Annual Audited Consolidated 51 Continuing Ops 51 Lifts FY# EPS 51 #-#/# #-#/# Change [001] 51 Nonoperating 51 SEK -#.# [001] 51 #-#/# [022] 51 - Net [011] 51 INTERIM FINANCIAL STATEMENTS 51 Files Restated 51 Fracture Risk 51 Months Months Ended 51 Drilling Activity 51 Discontinued Operation 51 Guides Q2 51 Non GAAP Proforma 51 Taxable equivalent 51 Profit Declines Quick Facts 51 -exhaust tailpipe 51 OTHER OPERATIONS 51 CONSOLIDATED BALANCE SHEET UNAUDITED 51 -liberally substituted 51 FAS CAS pension 51 Load Cells 51 INR#.#bn [004] 51 Observational Studies 51 Cashflow Report 51 Normalized EPS 51 Fourth Consecutive Quarter 51 Reaffirms FY# Revenue 51 Cash Flows Used 51 Seasonal Pattern 51 GROUP PJC INC. 51 Q1 #F 51 Ended - [019] 51 Pro forma Pro forma 51 Q2 FY# [002] 51 -ffxi 51 Reevaluation 51 Clinical Diagnostics segment 51 PALADIN ENERGY LTD 51 REVIEW OF OPERATIONS 51 Rs #.# lacs [002] 51 Rs.#.# Cr [003] 51 Discontinued Ops 51 - Operating [019] 51 Reclassifications 51 EUR#.#B [002] 51 Unfavourable Changes 51 condensed consolidated balance sheets 51 R'# R'# R'# 51 Subscriber Additions 51 -Laemmle Music 51 -Uni directional 51 Komax Group 51 Domestic Car Rental 51 EBITA amounted 51 andoperating 51 proforma revenues 51 CORPORATE GOVERNANCE STATEMENT 51 STATISTICS Unaudited 51 Q3 YTD 51 #Q# #Q# [003] 51 Widens Quick Facts 51 MedSurg Equipment 51 % unannualized 51 financialstatements 51 Clinical Relevance 51 audited audited 51 Condensed Consolidated 51 Inc. LATEST NEWS 51 MEUR -#.# 51 EXECUTIVE SUMMARY 51 MDRD 51 -Andrea Seabrook 51 Radiofrequency Ablation 51 Sees FY 51 -ecoterrorism 51 SEK -# 51 Supplementary Information 51 - - [060] 51 AvalonBay Communities Announces 51 Calorimetry 51 Anhui Jucheng 51 WEIGHTED AVG 51 Quarter Comparison 51 REPORTED GAAP 51 Corporate Overhead 51 #Q# YTD 51 totaled MEUR 51 Anworth Announces 51 Noninterest Expenses 51 Key Ratios 51 Q#/# EUR [001] 51 Revised Guidance 51 Results Reflect 51 Unallocated expenses 51 - -plumbers pipefitters 51 - - [113] 51 Three Month Periods 51 OPERATING REVENUE 51 Gastrointestinal Stromal Tumors 51 -strutted confidently 51 QTR QTR 51 -GUSTAV SANDSTROM 51 - Adjusted [034] 51 restated restated -INC. SEGMENT INFORMATION 51 - Adjusted [009] 51 Items Impacting Comparability 51 Clinical Practice Guideline 51 adjusted2 51 - Revenues [003] 51 REBIT 51 Consolidated Adjusted EBITDA 51 Organizational Structure 51 Infrared Optics 51 Non GAAP noninterest expense 51 #,# #,# -#,# [002] 51 Lead Fabricating 51 #Q# #Q# Var 51 NET INCOME AS REPORTED 51 Appendix 4E Preliminary 51 Finished Goods 51 Independent Leg Jackup 51 Gross Margins 51 Innovium Announces 51 Subtypes 51 Supplemental Schedules 51 .execute arbitrary SQL 51 - -Kratofil 51 Continuing Operations Unaudited 51 Q4 FY# [001] 51 ended December# 51 RUB#.# [004] 51 SUMMARY TABLE 51 Generics Segment 51 - Jim Clack 51 - AdjusETON 51 -Mullaloo 51 -# TEUR 51 #Q# Earnings Release 51 Reportable Segments 51 quarter offiscal 51 -DD2 51 Plasma Fractions 51 FISCAL YEAR 51 Randomized Placebo Controlled Trial 50 SUMMARY OF RESULTS 50 reportable segment 50 Segment Profit 50 Supplemental Data 50 - Unaudited [001] 50 Expenses Incentive 50 Coated Fabrics 50 Indirect Costs 50 # - -Huddinge 50 RISKS AND UNCERTAINTIES 50 Pro Forma 50 HY# 50 Calgon Carbon Announces 50 - UnaudCrouppen 50 QUARTER TO DATE 50 #-#/# [013] 50 standardized distributable cash 50 Qtrs 50 Change - [010] 50 Sono Tek Announces 50 Q3 FY# [001] 50 - - [087] 50 - Operating [029] 50 Blood Glucose Testing 50 Trans Lux Reports 50 High Temperature Superconductor 50 .W. McNichols 50 #,# #,# #,# [002] 50 Allomak Limited 50 #bp QoQ 50 - -Bredbury 50 Statistical Summary 50 Prevalence Worldwide 50 BIOSCIENCES INC. 50 #.#-# b [002] 50 - - [054] 50 -Horntvedt 50 Backs FY# Revenue 50 Gastric Cancer 50 Hedging Relationships 50 CDATA pre 50 Unallocated corporate 50 EastGroup Properties Announces 50 Rolled Glass 50 unaudited unaudited Net 50 Variable Interest Entities FIN 50 Adjusted EBT 50 EUR#.# mn [002] 50 Symptom Checklist 50 Conductive Polymers 50 1H FY 50 IBERIABANK Corporation Reports 50 Resource Utilization 50 Reportable segments 50 - Adjusted [017] 50 Irvine Sensors Releases 50 PRODUCT FACTS 50 GAAP NON GAAP 50 APPENDIX 50 Medoro Resources Announces 50 - Adjusted [001] 50 d Reflects 50 - - Net [052] 50 Non Controlling Interests 50 noninterest expense decreased 50 NYMAGIC INC. Reports 50 Jetter AG 50 OPERATIONAL REVIEW 50 Och Ziff Funds 50 -# -# -1 50 Controlled Entities Directors 50 - Adjusted [028] 50 Retained Earnings Deficit 50 Macroscopic 50 ECU netbacks 50 USGAAP